Novartis Nears Deal to Buy Cholesterol-Drug Maker The Medicines Co. | wsj.com24 Novembre 2019
Novartis AG is nearing a deal to buy cholesterol-drug maker The Medicines Co. for nearly $7 billion, in an expensive bid to expand its reach in the lucrative market for heart treatments.
The pharmaceutical giant has agreed to pay $85 a share in a deal that could be announced this weekend, people familiar with the matter said.
continua a leggere cliccando il link sotto riportato
fotografia: da ricerca web